Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis

View source ↗

Summary

A pilot clinical trial investigating the role of gut flora in Myasthenia gravis sponsored by ProgenaBiome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Snippet

Sponsor: ProgenaBiome | Conditions: Myasthenia Gravis, Myasthenia Gravis, Generalized | Status: WITHDRAWN